期刊文献+

以无纺布编织型生物反应器为基础的生物型人工肝治疗暴发性肝功能衰竭 被引量:4

Effects of a non-woven fabric bioreactor based bioartificial liver on fulminant hepatic failure in pigs
原文传递
导出
摘要 目的设计一种新型生物型人工肝,评价其治疗暴发性肝功能衰竭的疗效。方法采用无纺布编织型生物反应器接种原代猪肝细胞构建生物型人工肝,对D-氨基半乳糖胺诱导的猪暴发性肝功能衰竭模型进行治疗。结果生物型人工肝治疗可显著降低受试动物血氨和血清L-乳酸浓度,稳定血糖水平,改善Fischer指数,并延长动物存活时间。结论以无纺布编制型生物反应器为基础构建的生物型人工肝对暴发性肝功能衰竭具有明显的肝支持作用,具有临床应用可行性。 Objective In this paper, the design of a bioartificial liver (BAL) based on nonwoven fiber bioreactor is described and evaluated using a pig fulminant liver failure model. Methods Fulminant liver failure (FHF) was induced with D-galactosamine hydrochloride in a dose of 1.3 g/kg body weight in each pig. 12 hours later, the pigs were divided into three groups.. (1) a BAL group (n = 5), in which pigs received BAL treatment with 1.0 to 1.3-10^9 hepatocytes for a duration of 6 hours, (2) a sham BAL group (n = 5), in which pigs received BAL treatment without bepatocyres, and (3) a FHF group (n = 5 ), in which pigs only received intensive care. Parameters related to liver function and animal survivals up to 168 h were determined. Results In the BAL group, blood ammonia and serum L-lactate levels were lower, and serum glucose levels and Fischer index were higher than those in the other two groups. The survival time of FHF pigs in the BAL group was significantly prolonged (106 ±23 h) compared with the sham BAL (43 ±8 h) and the FHF group (48 ±7 h). Conclusions The non-woven fabric bioreactor based BAL system appears to be effective in treatment of FHF in pigs.
出处 《中华传染病杂志》 CAS CSCD 北大核心 2006年第1期24-28,共5页 Chinese Journal of Infectious Diseases
基金 国家863重大专项基金资助(2003AA205150) 国家"十五"科技攻关课题(2004BA706B02-01)
关键词 人工 肝功能衰竭 急性 生物反应器 半乳糖胺 Liver, artificial Liver failure, acute Bioreactors Galactosamine Swine
  • 相关文献

参考文献19

  • 1Shakil AO,Kramer D,Mazariegos GV,et al.Acute liver failure:clinical features,outcome analysis,and applicability of prognostic criteria.Liver Transpl,2000,6:163-169.
  • 2Mas A,Rodes J.Fulminant hepatic failure.Lancet,1997,349:1081-1085.
  • 3Demetriou A.Support of the acutely failing liver.State of the art.Ann Surg,1998,228:14-15.
  • 4Chang T.Experimental artificial liver support with emphasis on fulminant hepatic failure:concepts and review.Semin Liver Dis,1986,6:148-158.
  • 5van de Kerkhove MP,Hoekstra R,van Gulik TM,et al.Large animal models of fulminant hepatic failure in artificial and bioartificial liver support research.Biomaterials,2004,25:1613-1625.
  • 6Terblanche J,Hickman R.Animal models of fulminant hepa tic failure.Dig Dis Sci,1991,36:770-774.
  • 7Kalpana K,Ong HS,Soo KC,et al.An improved model of galactosamine-induced fulminant hepatic failure in the pig.J Surg Res,1999,82:121-130.
  • 8Williams R,Gimson A.Intensive liver care and management of acute hepatic failure.Dig Dis Sci,1991,36:820-826.
  • 9Ellis WR,Chu PK,Murray-Lyon IM.The influence of ammonia and octanoic acid on liver regeneration in the rat.Clin Sci,1979,56:95-97.
  • 10Zieve L,Shekleton M,Lyftogt C,et al.Ammonia,octanoate and a mercaptan depress regeneration of normal rat liver after partial hepatectomy.Hepatology,1985,5:28-31.

同被引文献20

引证文献4

二级引证文献53

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部